Pancreatic surgery

Current Opinion in Gastroenterology

Volumn 22, Issue 5, 2006, Pages 520-526

  Hines, Oscar J ^a   Reber, Howard A ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Adjuvant therapy; Chronic pancreatitis; Cystic tumor; Intraductal papillary mucinous tumor; Multiple endocrine neoplasia; Pancreatic adenocarcinoma; Pancreatic neoplasm

Indexed keywords

ANTINEOPLASTIC AGENT; BEVACIZUMAB; CARCINOEMBRYONIC ANTIGEN; CISPLATIN; FLUOROURACIL; GEMCITABINE; MITOMYCIN; MITOXANTRONE; SOMATOSTATIN; SOMATOSTATIN DERIVATIVE; STARCH MICROSPHERE; VASCULOTROPIN;

ABDOMINAL BLEEDING; ALGORITHM; ASPIRATION BIOPSY; CANCER COMBINATION CHEMOTHERAPY; CANCER RADIOTHERAPY; CHRONIC PANCREATITIS; COMPUTER ASSISTED TOMOGRAPHY; CYSTADENOMA; CYTOPATHOLOGY; ENDOSCOPIC ECHOGRAPHY; ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY; ENTERIC FEEDING; FREY OPERATION; GASTROJEJUNOSTOMY; GASTROSTOMY; HUMAN; INOPERABLE CANCER; INSULINOMA; INTRADUCTAL PAPILLARY MUCINOUS TUMOR; KAPLAN MEIER METHOD; LAPAROSCOPIC SURGERY; LAPAROTOMY; LENGTH OF STAY; LYMPH NODE DISSECTION; MORBIDITY; MULTIPLE ENDOCRINE NEOPLASIA; NUCLEAR MAGNETIC RESONANCE IMAGING; OPERATION DURATION; PANCREAS ADENOCARCINOMA; PANCREAS CANCER; PANCREAS FISTULA; PANCREAS SURGERY; PANCREATICODUODENECTOMY; PARENTERAL NUTRITION; PERCUTANEOUS DRAINAGE; POSTOPERATIVE COMPLICATION; PREOPERATIVE TREATMENT; REVIEW; STENT; STOMACH EMPTYING; SURGICAL MORTALITY; SURGICAL STAPLING; SURGICAL TECHNIQUE; SURVIVAL RATE; SURVIVAL TIME; SYSTEMATIC REVIEW; VIPOMA; ZOLLINGER ELLISON SYNDROME;

ADENOCARCINOMA; CARCINOMA, PANCREATIC DUCTAL; PANCREATIC DISEASES; PANCREATIC NEOPLASMS;

EID: 33746899298     PISSN: 02671379     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.mog.0000239866.81586.f6     Document Type: Review

References (24)

1. Kindler HL, Friberg G, Singh DA, et al. Phase II trial of bevacizumab plus gemcitabine in patients with advanced pancreatic cancer. J Clin Oncol 2005; 1:8033-8040.
2. Crane CH, Ellis LM, Abbruzzese JL, et al. Phase I trial evaluating the safety of bevacizumab with concurrent radiotherapy and capecitabine in locally advanced pancreatic cancer. J Clin Oncol 2006; 24:1145-1151.
3. Aigner KR, Gailhofer S. Celiac axis infusion and microembolization for advanced stage III/IV pancreatic cancer: a phase II study on 265 cases. Anticancer Res 2005; 25 (6C):4407-4412.
4. Mullen JT, Lee JH, Gomez HF, et al. Pancreaticoduodenectomy after placement of endobiliary metal stents. J Gastrointest Surg 2005; 9:1094-1104.
5. Kuhlmann K, de Castro S, van Heek T, et al. Microscopically incomplete resection offers acceptable palliation in pancreatic cancer. Surgery 2006;139:188-196.
6. van Heek NT, Kuhlmann KF, Scholten RJ, et al. Hospital volume and mortality after pancreatic resection: a systematic review and an evaluation of intervention in the Netherlands. Ann Surg 2005; 242:781-788. This large multiinstitutional study of over 19 000 patients who underwent pancreatic resection confirms that operative volume appears to dictate outcome in the Netherlands.
7. Fong Y, Gonen M, Rubin D, et al. Long-term survival is superior after resection for cancer in high-volume centers. Ann Surg 2005; 242:540-544. This large Medicare study demonstrates that the operative volume also dictates survival of patients with pancreatic cancer, and not just morbidity and mortality.
8. Seiler CA, Wagner M, Bachmann T, et al. Randomized clinical trial of pylorus-preserving duodenopancreatectomy versus classical Whipple resection: long term results. Br J Surg 2005; 92:547-556.
9. Bassi C, Falconi M, Molinari E, et al. Reconstruction by pancreaticojejunostomy versus pancreaticogastrostomy following pancreatectomy: results of a comparative study. Ann Surg 2005; 242:767-771.
10. Standop J, Overhaus M, Schaefer N, et al. Pancreatogastrostomy after pancreatoduodenectomy: a safe, feasible reconstruction method? World J Surg 2005; 29:505-512.
11. Hartel M, Wente MN, Hinz U, et al. Effect of antecolic reconstruction on delayed gastric emptying after the pylorus-preserving Whipple procedure. Arch Surg 2005; 140:1094-1099.
12. Farnell MB, Pearson RK, Sarr MG, et al. A prospective randomized trial comparing standard pancreatoduodenectomy with pancreatoduodenectomy with extended lymphadenectomy in resectable pancreatic head adenocarcinoma. Surgery 2005; 138:618-628. This large randomized study confirms other recently published randomized studies finding that an extended lymphadenectomy does not improve survival for patients with pancreatic cancer.
13. Balzano G, Zerbi A, Cristallo M, et al. The unsolved problem of fistula after left pancreatectomy: the benefit of cautious drain management. J Gastrointest Surg 2005; 9:837-842.
14. Kazanjian KK, Hines OJ, Eibl G, et al. Management of pancreatic fistulas after pancreaticoduodenectomy: results in 437 consecutive patients. Arch Surg 2005; 140:849-854.
15. Connor S, Alexakis N, Garden OJ, et al. Meta-analysis of the value of somatostatin and its analogues in reducing complications associated with pancreatic surgery. Br J Surg 2005; 92:1059-1067. This metaanalysis includes the largest and best studies examining the use of somatostatin and suggests that perioperative somatostatin may decrease perioperative morbidity and pancreatic fistulas.
16. Bartsch DK, Fendrich V, Langer P, et al. Outcome of duodenopancreatic resections in patients with multiple endocrine neoplasia type 1. Ann Surg 2005; 242:757-764.
17. Triponez F, Dosseh D, Goudet P, et al. Epidemiology data on 108 MEN 1 patients from the GTE with isolated nonfunctioning tumors of the pancreas. Ann Surg 2006; 243:265-272.
18. Tseng JF, Warshaw AL, Sahani DV, et al. Serous cystadenoma of the pancreas: tumor growth rates and recommendations for treatment. Ann Surg 2005; 242:413-419.
19. Lim SJ, Alasadi R, Wayne JD, et al. Preoperative evaluation of pancreatic cystic lesions: cost-benefit analysis and proposed management algorithm. Surgery 2005; 138:672-679. An algorithm for the evaluation and treatment of cystic lesions of the pancreas is very helpful with this increasingly difficult problem.
20. Lee SY, Lee KT, Lee JK, et al. Long-term follow up results of intraductal papillary mucinous tumors of pancreas. J Gastroenterol Hepatol 2005; 20:1379-1384.
21. Wada K, Kozarek RA, Traverso LW. Outcomes following resection of invasive and noninvasive intraductal papillary mucinous neoplasms of the pancreas. Am J Surg 2005; 189:632-636.
22. Mabrut JY, Fernandez-Cruz L, Azagra JS, et al. Laparoscopic pancreatic resection: results of a multicenter European study of 127 patients. Surgery 2005; 137:597-605.
23. Strate T, Taherpour Z, Bloechle C, et al. Long-term follow-up of a randomized trial comparing the Beger and Frey procedures for patients suffering from chronic pancreatitis. Ann Surg 2005; 241:591-598.
24. Frey CF, Reber HA. Local resection of the head of the pancreas with pancreaticojejunostomy. J Gastrointest Surg 2005; 9:863-868.